Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
The Covid 19 incidence rate has dropped below 250 for the first time since Christmas. In the Alpes-Maritimes, it currently stands at .. .....
Read More
France’s employment minister Elisabeth Borne has said this morning that she wants "priority access" to vaccination for binmen and bus drivers over 55 ...
Read More
After more than two weeks of lockdown the number of intensive care patients in France has dropped slightly below 5,900. With health authorities claim...
Read More
French Health Minister Olivier Veran has said that the level of circulation of the virus in France is "too high" and the lifting of the curfew "is not...
Read More
